QQ
微信
| | 英文名称 | | 中文名称 | | CAS |
|---|---|---|
| Labetuzumab Govitecan | Labetuzumab Govitecan | 1469876-18-3 |
| Vofatamab | VOFATAMAB (沃凡妥单抗 ) | 1312305-12-6 |
| Lumiliximab | LUMILIXIMAB ( 鲁昔单抗 ) | 357613-86-6 |
| Cantuzumab Ravtansine | Cantuzumab Ravtansine | 868747-45-9 |
| Parsatuzumab | 帕萨妥珠单抗 | 1312797-14-0 |
| Duvortuxizumab | Duvortuxizumab | 1831098-91-9 |
| Dilpacimab | Dilpacimab | 1791420-09-1 |
| Atoltivimab | ATOLTIVIMAB (阿替韦单抗 ) | 2135632-29-8 |
| Etigilimab | 艾替利单抗 | 2044984-83-8 |
| Camidanlumab | 卡利尤单抗 | 921618-45-3 |
| Tamrintamab Pamozirine | TAMRINTAMAB PAMOZIRINE (帕他林妥单抗 ) | 2148334-68-1 |
| Margetuximab | 玛格妥昔单抗 | 1350624-75-7 |
| HuCC49 | HuCC49 | 823788-82-5 |
| Lebrikizumab | 来瑞组单抗 | 953400-68-5 |
| Cinpanemab | CINPANEMAB (辛帕奈单抗 ) | 2094516-02-4 |
| Berlimatoxumab | Berlimatoxumab | 1939109-24-6 |
| Inclacumab | Inclacumab | 1256258-86-2 |
| Samrotamab Vedotin | Samrotamab Vedotin | 2052649-42-8 |
| Evinacumab | Evinacumab | 1446419-85-7 |
| Losatuxizumab | Losatuxizumab | 1801544-27-3 |
